Skip to main content
Oncopeptides logo

Oncopeptides — Investor Relations & Filings

Ticker · ONCO ISIN · SE0009414576 LEI · 549300J9WWQ5CBYQ1M77 ST Manufacturing
Open in API
Filings indexed 483 across all filing types
Latest filing 2026-04-28 Annual Report (ESEF)
Country SE Sweden
Listing ST ONCO

About Oncopeptides

https://www.oncopeptides.com/en

Oncopeptides is a biotechnology company focused on the research, development, and commercialization of targeted therapies for difficult-to-treat cancers. The company concentrates on hematological diseases, with a primary focus on multiple myeloma. Its commercialized product is Pepaxti (melflufen), a peptide-drug conjugate for adult patients with relapsed or refractory multiple myeloma. Founded in 2000 based on research from leading cancer institutions, Oncopeptides leverages its proprietary technology platforms to advance a pipeline of innovative drug candidates. The company's research also includes the development of Natural Killer (NK) cell engagers to address unmet medical needs in oncology.

Recent filings

Filing Released Lang Actions
Annual Report (ESEF) 2025
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-04-28 Swedish
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a Swedish Financial Supervisory Authority (Finansinspektionen) “flaggningsmeddelande” showing a third‐party investor (Avanza Bank Holding AB via its subsidiary) crossing the 5% ownership threshold in Oncopeptides AB, with detailed pre‐ and post‐transaction share counts and percentages. This is a Major Shareholding Notification under takeover/market disclosure rules, matching our Major Shareholding Notification (MRQ) category.
2026-04-24 Swedish
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a "flaggningsmeddelande" published by the Swedish Financial Supervisory Authority (Finansinspektionen) detailing a purchase that crosses the 5% voting rights threshold for Oncopeptides AB. It contains specific share counts before and after the transaction and references LHF (Swedish flagging law) requirements. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-04-21 Swedish
Årsstämma i Oncopeptides
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Swedish press release calling shareholders to the 2026 Annual General Meeting of Oncopeptides AB. It provides detailed instructions for registration, participation (in person or by pre-voting), the full agenda, and the board’s proposals on resolutions to be voted on. This is not the annual report itself nor an earnings release or a simple announcement of publication; rather, it is information and materials sent to shareholders to solicit votes at the meeting. Therefore, it best fits the Proxy Solicitation & Information Statement category.
2026-04-16 Swedish
Annual General Meeting in Oncopeptides
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice and information circular for Oncopeptides AB’s upcoming Annual General Meeting, detailing registration and voting procedures, the meeting agenda, and the Nomination Committee’s proposals. It is not the company’s annual report or auditor’s report but rather proxy solicitation materials sent to shareholders to inform them of meeting matters and request their votes. This aligns with the definition for Proxy Solicitation & Information Statement (PSI).
2026-04-16 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 1% confidence The document is a Swedish flagging notification published by Finansinspektionen detailing a sale by Avanza Bank Holding AB on behalf of its insurance subsidiary, reporting changes in shareholding and voting rights crossing the 5% threshold. This aligns with the definition of a Major Shareholding Notification (MRQ).
2026-04-10 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.